Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
2 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
AbCellera
company in Vancouver, Canada
Nothing else this week.
Related events
- Cantor Fitzgerald provided research reports on Cabaletta Bio, a company whose stock trades on Nasdaq.
- Cantor Fitzgerald affiliates organized a Special Purpose Acquisition Company (SPAC).
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald initiated coverage with an overweight rating and price target for a company debuting on the New York Stock Exchange.
- Cantor Fitzgerald raised its price target on Texas Instruments shares on July 8, 2026.